Quote | ClearPoint Neuro, Inc. (NASDAQ:CLPT)
Last: | $5.32 |
---|---|
Change Percent: | -0.36% |
Open: | $5.52 |
Close: | $5.32 |
High: | $5.52 |
Low: | $5.27 |
Volume: | 58,860 |
Last Trade Date Time: | 04/24/2024 03:00:00 am |
News | ClearPoint Neuro, Inc. (NASDAQ:CLPT)
2024-04-25 02:30:00 ET Summary ClearPoint Neuro's stock is down due to a recent equity raise and concerns about rising interest rates. The company is expanding its product portfolio and driving adoption of existing products with new software releases and FDA clearances. The re...
SOLANA BEACH, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced it has initiated the Limited Market Release fo...
Message Board Posts | ClearPoint Neuro, Inc. (NASDAQ:CLPT)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $CLPT News Article - ClearPoint Neuro Announces ANVISA Approval of Neuro Navigation Por | whytestocks | investorshangout | 04/13/2023 8:15:53 PM |
whytestocks: $CLPT News Article - ClearPoint Neuro Reports Fourth Quarter and Full-Year 2022 Results | whytestocks | investorshangout | 03/01/2023 9:15:45 PM |
whytestocks: $CLPT News Article - ClearPoint Neuro Announces FDA Clearance for ClearPoint Prism(TM) | whytestocks | investorshangout | 09/23/2022 1:55:47 PM |
whytestocks: $CLPT News Article - ClearPoint Neuro to Present Investigational Research and Exhibit a | whytestocks | investorshangout | 05/13/2022 3:50:53 PM |
50% haircut last 6 months. Glad I | MasterBlastr | investorshub | 04/05/2022 10:18:48 PM |
News, Short Squeeze, Breakout and More Instantly...
ClearPoint Neuro, Inc. Company Name:
CLPT Stock Symbol:
NASDAQ Market:
SOLANA BEACH, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced it has initiated the Limited Market Release fo...
SOLANA BEACH, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene t...
SOLANA BEACH, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced that it will release financial results for its...